DICOT — Dicot Pharma AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK782.64m
- SEK713.44m
- SEK0.20m
Annual cashflow statement for Dicot Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -27.2 | -31.7 | -44.2 | -57.7 | -79.9 |
| Depreciation | |||||
| Non-Cash Items | 0 | -0.033 | 0 | 0.03 | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.3 | 2.03 | -1.08 | -1.21 | -5.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -25.9 | -29.7 | -45.2 | -58.9 | -85.8 |
| Capital Expenditures | 0 | 0 | 0 | — | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | 0 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow Items | — | — | — | — | -2.2 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 35.9 | 8.76 | 83.2 | 125 | 41.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10 | -21 | 38 | 66.1 | -44.2 |